Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1623 (LINC01623)
- Target
- LINC01623
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Non-protein coding RNA
01
Overview
Long intergenic non-protein coding RNA 1623 (LINC01623) is a human long intergenic non-coding RNA (lincRNA) gene, which produces non-protein coding RNA transcripts longer than 200 nucleotides and does not overlap protein-coding genes[1][6]. LincRNAs, including LINC01623, act at the RNA level and may regulate gene expression through various mechanisms such as chromatin modification, transcriptional regulation, or post-transcriptional actions, frequently serving as decoys, scaffolds, or competitors in RNA-protein and RNA-RNA interactions[5][6]. Comprehensive functional characterization of LINC01623 is lacking, and it is not currently recognized as a canonical therapeutic target (e.g., receptor, enzyme) or as a validated biomarker. Its precise physiological and disease roles, as well as drug interactions, remain undetermined.
- Other names
- XXbac-BPG308K3.6LINC01623
02
Biological functions
Gene regulation (potential/putative)Epigenetic modification (general property of lincRNAs)Transcriptional regulation (general property of lincRNAs)Post-transcriptional regulation (general property of lincRNAs)
03
Disease associations
Cancer (lncRNAs, including some lincRNAs, are implicated in cancer; however, there is no explicit disease association described for LINC01623)Other (lncRNAs can be involved in diverse diseases, but for LINC01623, specific associations are unconfirmed)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1623 (LINC01623).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1623 (LINC01623).